Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.30M | -2.45M | -3.11M | -3.28M | -3.48M |
| Total Depreciation and Amortization | 363.00K | 370.90K | 326.20K | 270.50K | 208.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 1.15M | 1.65M | 1.68M | 1.66M |
| Change in Net Operating Assets | 970.50K | 669.10K | 438.90K | 636.60K | 919.90K |
| Cash from Operations | 89.20K | -253.60K | -689.70K | -692.30K | -692.10K |
| Capital Expenditure | 0.00 | -600.00 | -4.60K | -4.60K | -4.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.87M | 1.87M | -- | -- | -- |
| Cash from Investing | 1.87M | 1.87M | -4.60K | -4.60K | -4.60K |
| Total Debt Issued | -1.84M | -1.75M | 734.60K | 374.00K | 122.90K |
| Total Debt Repaid | -500.40K | -444.40K | -100.90K | -283.80K | -383.80K |
| Issuance of Common Stock | -- | -- | 25.40K | 500.40K | 809.40K |
| Repurchase of Common Stock | -377.60K | -377.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 377.60K | 377.60K | 377.60K | 377.60K |
| Cash from Financing | -2.00M | -1.62M | 743.80K | 697.20K | 666.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -300.00 | -300.00 | -300.00 | -46.10K | -- |
| Net Change in Cash | -43.40K | -8.80K | 49.30K | -45.80K | -29.90K |